{"id":817480,"date":"2025-02-25T08:11:43","date_gmt":"2025-02-25T13:11:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/"},"modified":"2025-02-25T08:11:43","modified_gmt":"2025-02-25T13:11:43","slug":"upstream-bio-to-present-at-upcoming-march-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/","title":{"rendered":"Upstream Bio to Present at Upcoming March Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WALTHAM, Mass., Feb.  25, 2025  (GLOBE NEWSWIRE) &#8212; Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Upstream Bio\u2019s CEO, will present at the following upcoming March investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>TD Cowen 45th Annual Health Care Conference, Boston MA<br \/><\/strong>Tuesday, March 4, 2025, 11:50 a.m. \u2013 12:20 p.m. ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Leerink Partners Global Biopharma Conference 2025, Miami FL<\/strong><br \/>\n          <br \/>Wednesday, March 12, 2025, 1:40 p.m. \u2013 2:10 p.m. ET<\/li>\n<\/ul>\n<p>A live webcast of the presentation will be available under the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PVsBPrNar9sy0EOfCmwPOIf8gb7rWuDYxBeabX_j0zmNS1GlBC-9g7_YthAS8iCU8MYrSkHqbqAb4ql_jLd6wRt9htVqBCfJ68X_mNZZdWc=\" rel=\"nofollow\" target=\"_blank\">\u201c<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Z3fkD4lh4961LbPUXuVtHKS-er4fgiH9BrRzkq68LH84WQ9SZaOckVcYlCUaB9voaTuMPR5fWajQh7IfYjn6sCWrKzobv3In5PEcldNfmJuew8Xo3NeE-weiXetzbKtg\" rel=\"nofollow\" target=\"_blank\">Events<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=18mhQczbv0a6Ogz8FupQ06Fbm6nBUKASUAouZ0s2rUBANUiFWOrajgxtuQUlsWkrEfxPI38Sb6HHrN5eEbXnHRGmYuklg-hdZRxoMvhKjOY=\" rel=\"nofollow\" target=\"_blank\">\u201d<\/a> tab on the \u201cInvestors\u201d page of the Company&#8217;s website on the day of the event. A replay of the webcast will be posted on the Company&#8217;s website following the presentation.<\/p>\n<p>\n        <strong>About Upstream Bio<\/strong>\n      <\/p>\n<p>Upstream Bio is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist currently in clinical development that targets the receptor for thymic stromal lymphopoietin, a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. The Company has advanced this highly potent monoclonal antibody into separate Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and plans to initiate development in chronic obstructive pulmonary disease. Upstream Bio\u2019s team is committed to maximizing verekitug\u2019s unique attributes to address the substantial unmet needs for patients underserved by today\u2019s standard of care. To learn more, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1qk6QclNM8Uw8fHvLWUmeYR04WVt5kPtWClGDOzK73JIX8KMcAIkmt6e9DKdWln0eowYEQypDUZf5vVG2YBIH04Iizb7BYx6q4J8AoTFy9o=\" rel=\"nofollow\" target=\"_blank\"><u>www.upstreambio.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Michael Gray<br \/>Chief Financial Officer and Chief Operating Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nRESzvKepkE67bj_7cmsERs1zOGjJdLFZanbSjxtirXB_7WSj_y9_s9a9ujemHG64irSLqev2xkJN8W74qGLaMb7d8nvxDc7RZBGbY13_sA=\" rel=\"nofollow\" target=\"_blank\"><u>ir@upstreambio.com<\/u><\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Teri Dahlman<br \/>Red House Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LWXipBbjJPCxDs7kV5X2oApy6kfo4LRnLSWe8efubi6M3urBh1sVrgxv4eq4ubO6NKQFkYJIKZcWnYzXIzJa5Z4tFCgomGqTP7dGH9ixsO8=\" rel=\"nofollow\" target=\"_blank\"><u>teri@redhousecomms.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NWY2OGEyMTgtNWUzNy00NGUwLTk4MGYtZjk4M2JjNjkxNjI1LTEzMDQyOTE=\/tiny\/Upstream-Bio.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Upstream Bio\u2019s CEO, will present at the following upcoming March investor conferences: TD Cowen 45th Annual Health Care Conference, Boston MATuesday, March 4, 2025, 11:50 a.m. \u2013 12:20 p.m. ET Leerink Partners Global Biopharma Conference 2025, Miami FL Wednesday, March 12, 2025, 1:40 p.m. \u2013 2:10 p.m. ET A live webcast of the presentation will be available under the \u201cEvents\u201d tab on the \u201cInvestors\u201d page of the Company&#8217;s website on the day of the event. A replay of the webcast will be posted on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Upstream Bio to Present at Upcoming March Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-817480","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Upstream Bio to Present at Upcoming March Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Upstream Bio to Present at Upcoming March Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Upstream Bio\u2019s CEO, will present at the following upcoming March investor conferences: TD Cowen 45th Annual Health Care Conference, Boston MATuesday, March 4, 2025, 11:50 a.m. \u2013 12:20 p.m. ET Leerink Partners Global Biopharma Conference 2025, Miami FL Wednesday, March 12, 2025, 1:40 p.m. \u2013 2:10 p.m. ET A live webcast of the presentation will be available under the \u201cEvents\u201d tab on the \u201cInvestors\u201d page of the Company&#8217;s website on the day of the event. A replay of the webcast will be posted on the &hellip; Continue reading &quot;Upstream Bio to Present at Upcoming March Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-25T13:11:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Upstream Bio to Present at Upcoming March Investor Conferences\",\"datePublished\":\"2025-02-25T13:11:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/\"},\"wordCount\":288,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/\",\"name\":\"Upstream Bio to Present at Upcoming March Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=\",\"datePublished\":\"2025-02-25T13:11:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/upstream-bio-to-present-at-upcoming-march-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Upstream Bio to Present at Upcoming March Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Upstream Bio to Present at Upcoming March Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Upstream Bio to Present at Upcoming March Investor Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) &#8212; Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Upstream Bio\u2019s CEO, will present at the following upcoming March investor conferences: TD Cowen 45th Annual Health Care Conference, Boston MATuesday, March 4, 2025, 11:50 a.m. \u2013 12:20 p.m. ET Leerink Partners Global Biopharma Conference 2025, Miami FL Wednesday, March 12, 2025, 1:40 p.m. \u2013 2:10 p.m. ET A live webcast of the presentation will be available under the \u201cEvents\u201d tab on the \u201cInvestors\u201d page of the Company&#8217;s website on the day of the event. A replay of the webcast will be posted on the &hellip; Continue reading \"Upstream Bio to Present at Upcoming March Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-25T13:11:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Upstream Bio to Present at Upcoming March Investor Conferences","datePublished":"2025-02-25T13:11:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/"},"wordCount":288,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/","name":"Upstream Bio to Present at Upcoming March Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=","datePublished":"2025-02-25T13:11:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4Mzk1MiM2Nzc2NjM1IzIyOTI3NDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/upstream-bio-to-present-at-upcoming-march-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Upstream Bio to Present at Upcoming March Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=817480"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/817480\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=817480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=817480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=817480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}